bullish
Innovent Biologics Placement - Positive Newsflow but Past Deal Performance Weighs
521 Views03 Oct 2019 18:57
Innovent Biologics is raising USD 314 million to fund its clinical trial in a top-up placement. We have covered the company's listing and the...
SUMMARY
(Sign Up to Access)Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
- Unlock research summaries
- Follow top, independent analysts
- Receive personalised alerts
- Access Analytics, Events and more
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.
Upgrade later to our paid plans for full-access.
or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 3-minute read)
Discussions
(Paid Plans Only)
Price Chart(Sign Up to Access)
- Innovent Biologics (信达生物) Placement - Back on the Market but This Time with Secondary Selldown22 Jul 2020
- Innovent Biologics Placement: Positive Newsflow Bodes Well for Capital Raising12 Feb 2020
- Innovent Biologics - Promising Phase I Results for Lung Cancer09 Oct 2019
- Innovent Biologics (信达生物) Placement - Selling upon Lock-Up Expiry16 Apr 2019
- Keytruda Approved for Lung Cancer Treatment in China - A Review of PD-1 Battle Field11 Apr 2019
x